APOE and Alzheimer disease: Carriers of both APOE4 and BCHE-K alleles in the MCI stage of AD have a limbic-amnestic phenotype and progress most rapidly in the mild stage of AD, where they are the only genotype group with a significant response to AChE-I treatment [27, 31–33].